LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹9,336 Cr | ₹8,387 Cr | ₹7,660 Cr | ₹6,968 Cr | ₹5,751 Cr |
What is the latest Total Liabilities ratio of LAURUS LABS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹9,336 Cr |
| Mar2024 | ₹8,387 Cr |
| Mar2023 | ₹7,660 Cr |
| Mar2022 | ₹6,968 Cr |
| Mar2021 | ₹5,751 Cr |
How is Total Liabilities of LAURUS LABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,336 Cr | 11.31 | |
| Mar2024 | ₹8,387 Cr | 9.49 | |
| Mar2023 | ₹7,660 Cr | 9.94 | |
| Mar2022 | ₹6,968 Cr | 21.17 | |
| Mar2021 | ₹5,751 Cr | - | |
Compare Total Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹61,278.7 Cr | 3.4% | 13.1% | 100.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 3.4% |
13.1% |
100.5% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses